Over the last fifty years, Indian pharmaceutical stocks have seen remarkable growth both domestically and globally. From a mere 5% share in medicine consumption in 1969 to a robust 80% in 2020, Indian pharma companies have made significant strides. Now recognized as the third-largest in volume and thirteenth-largest in value, these companies are drawing substantial investor interest.
Pharma sector stocks are ideal for both top-down and bottom-up investing approaches and are often regarded as defensive stocks. This article will explore popular Indian pharma companies for 2024 investment and examine the factors shaping the industry, including a look at some popular pharma Baskets.
Pharma stocks represent companies operating in the pharmaceutical industry, involved in research, development, manufacturing, and distribution of drugs and medicines. This includes producing prescription drugs, over-the-counter medicines, and generic drugs.
The pharma sector is a significant contributor to India’s economic growth. Here are some of the best pharma stocks to consider:
The pharma sector has been crucial in India’s economic growth. If you are considering investment, here’s a list of some of the best pharma stocks:
Company Name | Sub-Sector | Market Cap (in Cr) | Stock Price |
---|---|---|---|
Sun Pharmaceutical Industries Ltd | Pharmaceuticals | ₹2,34,822 | ₹1,116.45 |
Divi’s Laboratories Ltd. | Labs & Life Sciences Services | ₹85,970 | ₹3,643 |
Dr Reddy’s Laboratories Ltd | Pharmaceuticals | ₹81,725 | ₹5,666.7 |
Cipla Ltd | Pharmaceuticals | ₹73,770 | ₹1,241.5 |
Apollo Hospitals Enterprise Ltd | Hospitals & Diagnostic Centres | ₹63,516 | ₹4,875 |
Torrent Pharmaceuticals Ltd | Pharmaceuticals | ₹55,141 | ₹1,953.95 |
Zydus Lifesciences Ltd. | Pharmaceuticals | ₹52,093 | ₹629 |
Abbott India Ltd | Pharmaceuticals | ₹47,061 | ₹23,408.15 |
Max Healthcare Institute Ltd | Hospitals & Diagnostic Centres | ₹43,912 | ₹572.05 |
Alkem Laboratories Ltd | Pharmaceuticals | ₹41,076 | ₹3,711 |
Note: This list is for educational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing.
Investing in pharma shares comes with challenges, such as regulatory and patent risks, and currency fluctuations. However, FinPlay portfolios like Pharma Tracker can help mitigate these risks.
Pharma stocks are categorized into large-cap, mid-cap, and small-cap, based on market capitalization, with companies like Sun Pharma, Dr. Reddy’s Laboratories, and Cipla being some examples.
The pandemic has highlighted the Indian pharmaceutical industry’s capability, earning it the title of ‘Pharmacy of the world’. Many companies have redirected their drug development efforts to address the crisis.
This index comprises the top 10 pharmaceutical companies on the NSE, providing a benchmark for the sector’s performance.
Key factors include domestic and global demand, research and development investments, regulatory environment, intellectual property rights, and market competition.
Investing in pharma stocks offers steady demand, strong growth potential, high profitability, and dividends.
Suitable for long-term, income-oriented, risk-averse, value investors, and healthcare sector enthusiasts.
To Wrap It Up… The Indian pharma market shows promising growth potential in 2024. Investors can consider pharma stocks through FinPlay for diversified and risk-mitigated investment opportunities.
Best 3 Pharma Stocks?
How to Invest in Pharma Stocks?
Is it a Good Time for Pharma Stocks?
Who Should Invest?
Key Considerations for Pharma Stocks?
Are Pharma Stocks Risky?
Stay informed and up-to-date on various thematic sectors by exploring related articles:
Explore HSBC Mutual Fund's strategies, fund managers, and investment options for diverse investor profiles.
Discover Edelweiss Mutual Funds for diversified investment options, innovative strategies, and digital convenience.
Explore Bandhan Mutual Fund's diverse schemes, performance insights, and expert management for informed investment decisions…
Explore Tata Mutual Fund's diverse schemes for 2024, ideal for long-term growth, tax savings, and…
Discover Kotak Mutual Fund's dynamic investment strategies for 2024, top-performing funds, and expert fund managers…
Explore Nippon India Mutual Fund's top schemes for 2024, tailored for diverse investor profiles with…